Arcellx IncNASDAQ:ACLX
- LAST PRICE51.9200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots48.1100/ 1
- Ask / Lots65.2400/ 1
- Open / Previous Close0.0000 / 51.9200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACLX |
|---|---|---|
| 09:32 ET | 2034 | 51.06 |
| 09:34 ET | 2929 | 51.73 |
| 09:48 ET | 200 | 51.62 |
| 09:50 ET | 301 | 51.46 |
| 09:54 ET | 700 | 51.55 |
| 09:56 ET | 700 | 51.9 |
| 09:59 ET | 500 | 51.68 |
| 10:03 ET | 200 | 51.47 |
| 10:06 ET | 700 | 51.5 |
| 10:08 ET | 100 | 51.465 |
| 10:10 ET | 496 | 51.52 |
| 10:12 ET | 1332 | 51.7325 |
| 10:15 ET | 100 | 51.89 |
| 10:24 ET | 400 | 51.88 |
| 10:26 ET | 100 | 51.825 |
| 10:28 ET | 100 | 51.815 |
| 10:30 ET | 900 | 51.91 |
| 10:32 ET | 200 | 52.05 |
| 10:33 ET | 314 | 52.13 |
| 10:35 ET | 200 | 52.205 |
| 10:37 ET | 100 | 52.11 |
| 10:39 ET | 100 | 52.14 |
| 10:42 ET | 100 | 52.17 |
| 10:46 ET | 1138 | 51.94 |
| 10:48 ET | 100 | 52.01 |
| 10:51 ET | 2500 | 52 |
| 10:53 ET | 102 | 51.915 |
| 10:57 ET | 563 | 51.925 |
| 11:00 ET | 300 | 51.925 |
| 11:02 ET | 416 | 52.04 |
| 11:04 ET | 100 | 51.955 |
| 11:06 ET | 600 | 51.955 |
| 11:09 ET | 3000 | 51.885 |
| 11:11 ET | 400 | 51.85 |
| 11:13 ET | 200 | 51.835 |
| 11:15 ET | 400 | 51.85 |
| 11:18 ET | 400 | 51.43 |
| 11:20 ET | 500 | 51.5 |
| 11:24 ET | 2107 | 51.45 |
| 11:26 ET | 100 | 51.39 |
| 11:29 ET | 1500 | 51.445 |
| 11:31 ET | 280 | 51.465 |
| 11:45 ET | 200 | 51.55 |
| 11:47 ET | 500 | 51.77 |
| 11:49 ET | 4500 | 51.78 |
| 11:51 ET | 100 | 51.775 |
| 11:54 ET | 1700 | 51.71 |
| 11:56 ET | 10600 | 51.74 |
| 11:58 ET | 3200 | 51.93 |
| 12:02 ET | 400 | 51.91 |
| 12:03 ET | 100 | 51.915 |
| 12:05 ET | 200 | 51.995 |
| 12:07 ET | 300 | 51.98 |
| 12:09 ET | 100 | 51.985 |
| 12:12 ET | 438 | 52.0265 |
| 12:14 ET | 600 | 52.115 |
| 12:16 ET | 400 | 52.055 |
| 12:20 ET | 994 | 51.955 |
| 12:23 ET | 200 | 51.985 |
| 12:27 ET | 3000 | 52.135 |
| 12:30 ET | 800 | 52.1316 |
| 12:32 ET | 100 | 52.1 |
| 12:34 ET | 200 | 52.09 |
| 12:36 ET | 700 | 52.105 |
| 12:38 ET | 100 | 52.095 |
| 12:43 ET | 600 | 52.14 |
| 12:45 ET | 100 | 52.165 |
| 12:48 ET | 300 | 52.175 |
| 12:50 ET | 100 | 52.17 |
| 12:52 ET | 9657 | 52.005 |
| 12:54 ET | 600 | 52.07 |
| 12:56 ET | 200 | 52.1 |
| 12:57 ET | 600 | 52.115 |
| 12:59 ET | 400 | 52.19 |
| 01:01 ET | 400 | 52.1726 |
| 01:03 ET | 100 | 52.21 |
| 01:08 ET | 100 | 52.26 |
| 01:10 ET | 1000 | 52.16 |
| 01:12 ET | 400 | 52.21 |
| 01:14 ET | 200 | 52.23 |
| 01:15 ET | 213 | 52.28 |
| 01:19 ET | 118 | 52.34 |
| 01:21 ET | 300 | 52.37 |
| 01:24 ET | 100 | 52.39 |
| 01:28 ET | 900 | 52.48 |
| 01:30 ET | 1200 | 52.48 |
| 01:32 ET | 1000 | 52.575 |
| 01:33 ET | 500 | 52.61 |
| 01:35 ET | 1573 | 52.61 |
| 01:37 ET | 1129 | 52.415 |
| 01:39 ET | 100 | 52.4999 |
| 01:42 ET | 281 | 52.4 |
| 01:46 ET | 300 | 52.445 |
| 01:48 ET | 1575 | 52.43 |
| 01:50 ET | 600 | 52.47 |
| 01:51 ET | 200 | 52.435 |
| 01:53 ET | 500 | 52.46 |
| 01:55 ET | 1582 | 52.425 |
| 01:57 ET | 700 | 52.52 |
| 02:00 ET | 200 | 52.47 |
| 02:02 ET | 300 | 52.48 |
| 02:04 ET | 1510 | 52.49 |
| 02:06 ET | 1053 | 52.41 |
| 02:08 ET | 9350 | 52.245 |
| 02:09 ET | 200 | 52.16 |
| 02:11 ET | 200 | 52.225 |
| 02:13 ET | 29800 | 52.22 |
| 02:15 ET | 1900 | 52.03 |
| 02:20 ET | 1907 | 52.2 |
| 02:22 ET | 300 | 52.12 |
| 02:24 ET | 100 | 52.075 |
| 02:26 ET | 100 | 52.1 |
| 02:27 ET | 500 | 52.095 |
| 02:29 ET | 100 | 52.02 |
| 02:31 ET | 300 | 52.08 |
| 02:33 ET | 1372 | 51.95 |
| 02:36 ET | 200 | 51.93 |
| 02:38 ET | 600 | 51.98 |
| 02:40 ET | 265 | 51.98 |
| 02:42 ET | 500 | 52.025 |
| 02:45 ET | 800 | 52.01 |
| 02:47 ET | 700 | 52.08 |
| 02:54 ET | 400 | 52.24 |
| 02:56 ET | 200 | 52.24 |
| 02:58 ET | 1410 | 52.2 |
| 03:00 ET | 300 | 52.155 |
| 03:03 ET | 1032 | 52.05 |
| 03:05 ET | 400 | 52.01 |
| 03:07 ET | 100 | 52.08 |
| 03:09 ET | 300 | 52.08 |
| 03:12 ET | 100 | 52.08 |
| 03:14 ET | 100 | 52.08 |
| 03:16 ET | 826 | 52.16 |
| 03:18 ET | 3203 | 51.92 |
| 03:20 ET | 100 | 51.9 |
| 03:21 ET | 148 | 51.89 |
| 03:25 ET | 339 | 51.89 |
| 03:27 ET | 1025 | 52.06 |
| 03:30 ET | 500 | 52.11 |
| 03:32 ET | 709 | 52.14 |
| 03:34 ET | 428 | 52.08 |
| 03:36 ET | 2632 | 51.88 |
| 03:38 ET | 600 | 51.95 |
| 03:39 ET | 1034 | 51.86 |
| 03:41 ET | 905 | 51.75 |
| 03:43 ET | 811 | 51.575 |
| 03:45 ET | 538 | 51.53 |
| 03:48 ET | 1350 | 51.69 |
| 03:50 ET | 1521 | 51.905 |
| 03:52 ET | 3606 | 51.69 |
| 03:54 ET | 2245 | 51.67 |
| 03:56 ET | 6191 | 51.89 |
| 03:57 ET | 5211 | 51.93 |
| 03:59 ET | 64636 | 51.92 |
Apr 11, 2024
DJ Arcellx Price Target Maintained With a $81.00/Share by Needham, from 6:23AM ET on Thursday Apr 11, 2024 by Dow Jones
6:23AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 4, 2024
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference, from 4:00PM ET on Thursday Apr 04, 2024 by Dow Jones
4:00PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcellx Inc | 2.8B | -34.9x | --- |
Merus NV | 2.6B | -15.1x | --- |
Rhythm Pharmaceuticals Inc | 2.3B | -12.0x | --- |
CG Oncology Inc | 2.7B | -38.4x | --- |
NewAmsterdam Pharma Company NV | 2.0B | -8.1x | --- |
MoonLake Immunotherapeutics | 2.7B | -55.7x | --- |
Company Information
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Contact Information
- Headquarters
- 800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
- Phone
- 240-327-0603
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Rami Elghandour
- Chief Financial Officer
- Michelle Gilson
- Chief Medical Officer
- Christopher Heery
- Chief Commercial Officer
- Neeraj Teotia
- Independent Director
- Ali Behbahani
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
|---|---|
Revenue (TTM) | $110.3M |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.49 |
Book Value | $9.28 |
P/E Ratio | -34.9x |
Price/Sales (TTM) | 25.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
